시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 의약품 분야 RFID 시장 보고서(2025년)
Radio Frequency Identification (RFID) In Pharmaceuticals Global Market Report 2025
상품코드 : 1811016
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,362,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,196,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,031,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 의약품 분야 RFID 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년까지 CAGR 10.7%로 확대되어 91억 2,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장 배경으로는 위조 의약품 증가, 건강 관리 인식 증가, 병원 자동화 확대, 실시간 추적에 대한 수요 증가, 디지털 공급망 솔루션에 대한 투자 증가 등이 있습니다. 예측 기간의 주요 동향으로는 기술 진보, RFID 태그 설계 개선, 클라우드 기반 플랫폼과의 통합, 의약품 전용 인레이 개발, 공급망 디지털화의 진전 등이 있습니다.

위조 의약품 증가로 의약품 분야 RFID 시장의 향후 성장이 기대됩니다. 위조 의약품은 신원과 출처에 대해 의도적이고 부정하게 오표시된 의약품입니다. 위조 의약품의 급증은 온라인 약국의 급속한 확대가 주요 원인이며, 이로 인해 위조자가 기존의 규제 관리를 회피하고 위조 의약품을 소비자에게 직접 유통시키는 것이 용이하게 되어 적발 활동이 복잡해지고 있습니다. 의약품 RFID는 공급망의 모든 단계에서 제품의 진정성을 검증하는 안전하고 추적 가능한 데이터를 제공함으로써 위조 의약품 대책에 도움이 됩니다. 예를 들어 미국에 본사를 둔 비영리과학단체인 미국화학회는 2024년 12월, 2023년 142개국에서 6,987건의 위조 의약품 사건이 발생했다고 보고하였으며, 이는 2022년부터 4% 증가를 보이고 있습니다. 따라서 위조 의약품 사건 증가는 의약품에서 RFID 시장의 성장에 박차를 가하고 있습니다.

의약품 RFID 시장의 주요 기업은 제품 추적성 향상, 재고 관리 최적화, 위조 의약품 위협 증가에 대응하기 위해 첨단 RFID 대응 라벨 개발에 주력하고 있습니다. RFID 대응 라벨은 무선 주파수 기술을 이용하여 공급망 전체에서 의약품을 무선으로 식별, 추적, 인증하는 스마트 태그입니다. 예를 들어 2023년 5월 독일에 본사를 두고 있는 제약회사인 Fresenius Kabi AG는 헬스케어 환경에서의 약물 추적, 재고 관리, 환자의 안전성을 강화하기 위해 첨단 RFID 대응 라벨을 갖춘 로크로늄 브롬화물 주사액을 출시했습니다. 이 제품은 훈련받은 의료 종사자의 정맥 내 사용을 위해 5mL 당 50mg의 다회 투여 바이알로 제공됩니다. 이 주사제는 실시간 추적을 가능하게 하고, 재고 프로세스를 간소화하고, 투약 실수를 줄이는 데 도움이 되는 첨단 RFID 스마트 라벨링을 포함합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Radio frequency identification (RFID) in pharmaceuticals is a wireless technology that employs electronic tags equipped with chips and antennas to automatically identify, track, and manage medicines throughout the entire supply chain, from manufacturing to final use. This technology improves patient safety, ensures regulatory compliance, and optimizes operations by enabling fast, contactless, and precise verification of drug authenticity and movement at every stage.

The primary types of radio frequency identification (RFID) in pharmaceuticals include chipped radio frequency identification and chipless radio frequency identification. Chipped radio frequency identification involves RFID technology that utilizes tags embedded with microchips and antennas, permitting the storage and wireless transmission of unique identification data, tracking details, and product history. These can be read by compatible RFID readers for real-time authentication, monitoring, and management of pharmaceutical products across the supply chain. These systems are supported by various components such as RFID tags, RFID readers, middleware software, integration services, and data management software, and are implemented in accordance with regulatory compliance standards including Food and Drug Administration compliance, European Union Falsified Medicines Directive, Good Distribution Practices, serialization requirements, and tracking and tracing regulations. Radio frequency identification technologies are applied in multiple areas, including drug track and trace systems, asset tracking, patient safety, and other relevant applications, serving a diverse range of end users such as pharmaceutical manufacturers, hospitals and healthcare providers, pharmacies and drug wholesalers, research and development laboratories, and logistics and supply chain companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The radio frequency identification (RFID) in the pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides radio frequency identification (RFID) in the pharmaceuticals market statistics, including radio frequency identification (RFID) in the pharmaceuticals industry global market size, regional shares, competitors with a radio frequency identification (RFID) in the pharmaceuticals market share, detailed radio frequency identification (RFID) in the pharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the radio frequency identification (RFID) in the pharmaceuticals industry. This radio frequency identification (RFID) in the pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The radio frequency identification (RFID) in pharmaceuticals market size has grown rapidly in recent years. It will grow from $5.48 billion in 2024 to $6.08 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth during the historic period can be attributed to the increase in pharmaceutical exports, the rise of e-commerce, the growth in clinical trials, the demand for tamper-evident RFID solutions, and the expansion of patient-centric healthcare delivery models.

The radio frequency identification (RFID) in pharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $9.12 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to the increasing incidences of counterfeit drugs, rising healthcare awareness, expanding hospital automation, growing demand for real-time tracking, and increased investment in digital supply chain solutions. Key trends during the forecast period include technological advancements, improvements in radio frequency identification tag design, integration with cloud-based platforms, developments in pharmaceutical-specific inlays, and progress in supply chain digitization.

The rising incidents of counterfeit drugs are expected to drive the growth of the radio frequency identification (RFID) in pharmaceuticals market moving forward. Counterfeit drugs, also known as counterfeit medicines, are pharmaceutical products that are intentionally and fraudulently mislabeled regarding their identity or source. The surge in counterfeit drug cases is largely attributed to the rapid expansion of online pharmacies, which has made it easier for counterfeiters to distribute fake medicines directly to consumers, bypassing traditional regulatory controls and complicating detection efforts. RFID in pharmaceuticals helps combat counterfeit drugs by providing secure, traceable data that verifies product authenticity at every stage of the supply chain. For example, in December 2024, the American Chemical Society, a US-based nonprofit scientific organization, reported 6,987 counterfeit drug incidents across 142 countries in 2023, marking a 4% increase from 2022. Therefore, the rising cases of counterfeit drugs are fueling the growth of the RFID in pharmaceuticals market.

Leading companies in the RFID in pharmaceuticals market are concentrating on developing advanced RFID-enabled labels to improve product traceability, optimize inventory management, and counter the increasing threat of counterfeit drugs. RFID-enabled labels are smart tags that use radio frequency technology to wirelessly identify, track, and authenticate pharmaceutical products throughout the supply chain. For instance, in May 2023, Fresenius Kabi AG, a Germany-based pharmaceutical company, introduced Rocuronium Bromide Injection with advanced RFID-enabled labeling to enhance medication tracking, inventory control, and patient safety within healthcare settings. This product is supplied as a 50 mg per 5 mL multiple-dose vial for intravenous use by trained medical personnel. The injection incorporates advanced RFID smart labeling that enables real-time tracking, streamlines inventory processes, and helps reduce medication errors.

In April 2023, Impinj Inc., a US-based technology firm, acquired Voyantic Ltd for an undisclosed sum. With this acquisition, Impinj aims to bolster its position in the RFID industry and expand its portfolio with advanced RFID testing and measurement solutions to enhance performance and innovation. Voyantic Ltd. is a Finland-based company that specializes in RFID testing, measurement, and quality assurance solutions for RFID tags and systems used in pharmaceuticals.

Major players in the radio frequency identification (rfid) in pharmaceuticals market are Fujitsu Limited, NXP Semiconductors NV, Avery Dennison Corporation, Zebra Technologies Corporation, CCL Industries Inc., HID Global Corporation, Checkpoint Systems Inc, Datalogic SpA, Impinj Inc, Schreiner Group GmbH & Co KG, Invengo Information Technology Co Ltd, GAO RFID Inc., Lowry Solutions Inc., Terso Solutions Inc., Xerafy Singapore Pte Ltd., Tageos SAS, SML Group Limited, Syrma SGS Technology Limited, Omnia Technologies Private Limited, and identytag GmbH & Co KG.

North America was the largest region in the radio frequency identification (RFID) in pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in radio frequency identification (RFID) in pharmaceuticals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the radio frequency identification (RFID) in pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radio frequency identification (RFID) in pharmaceuticals market consists of revenues earned by entities providing services such as drug authentication, real-time tracking and tracing of medications, inventory management, anti-counterfeiting solutions, and regulatory compliance. The market value includes the value of related goods sold by the service provider or included within the service offering. The radio frequency identification (RFID) in pharmaceuticals market also includes sales of fixed readers, tracing systems, and verification systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radio Frequency Identification (RFID) In Pharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radio frequency identification (rfid) in pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for radio frequency identification (rfid) in pharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The radio frequency identification (rfid) in pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Radio Frequency Identification (RFID) In Pharmaceuticals Market Characteristics

3. Radio Frequency Identification (RFID) In Pharmaceuticals Market Trends And Strategies

4. Radio Frequency Identification (RFID) In Pharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Radio Frequency Identification (RFID) In Pharmaceuticals Growth Analysis And Strategic Analysis Framework

6. Radio Frequency Identification (RFID) In Pharmaceuticals Market Segmentation

7. Radio Frequency Identification (RFID) In Pharmaceuticals Market Regional And Country Analysis

8. Asia-Pacific Radio Frequency Identification (RFID) In Pharmaceuticals Market

9. China Radio Frequency Identification (RFID) In Pharmaceuticals Market

10. India Radio Frequency Identification (RFID) In Pharmaceuticals Market

11. Japan Radio Frequency Identification (RFID) In Pharmaceuticals Market

12. Australia Radio Frequency Identification (RFID) In Pharmaceuticals Market

13. Indonesia Radio Frequency Identification (RFID) In Pharmaceuticals Market

14. South Korea Radio Frequency Identification (RFID) In Pharmaceuticals Market

15. Western Europe Radio Frequency Identification (RFID) In Pharmaceuticals Market

16. UK Radio Frequency Identification (RFID) In Pharmaceuticals Market

17. Germany Radio Frequency Identification (RFID) In Pharmaceuticals Market

18. France Radio Frequency Identification (RFID) In Pharmaceuticals Market

19. Italy Radio Frequency Identification (RFID) In Pharmaceuticals Market

20. Spain Radio Frequency Identification (RFID) In Pharmaceuticals Market

21. Eastern Europe Radio Frequency Identification (RFID) In Pharmaceuticals Market

22. Russia Radio Frequency Identification (RFID) In Pharmaceuticals Market

23. North America Radio Frequency Identification (RFID) In Pharmaceuticals Market

24. USA Radio Frequency Identification (RFID) In Pharmaceuticals Market

25. Canada Radio Frequency Identification (RFID) In Pharmaceuticals Market

26. South America Radio Frequency Identification (RFID) In Pharmaceuticals Market

27. Brazil Radio Frequency Identification (RFID) In Pharmaceuticals Market

28. Middle East Radio Frequency Identification (RFID) In Pharmaceuticals Market

29. Africa Radio Frequency Identification (RFID) In Pharmaceuticals Market

30. Radio Frequency Identification (RFID) In Pharmaceuticals Market Competitive Landscape And Company Profiles

31. Radio Frequency Identification (RFID) In Pharmaceuticals Market Other Major And Innovative Companies

32. Global Radio Frequency Identification (RFID) In Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radio Frequency Identification (RFID) In Pharmaceuticals Market

34. Recent Developments In The Radio Frequency Identification (RFID) In Pharmaceuticals Market

35. Radio Frequency Identification (RFID) In Pharmaceuticals Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기